Auxly Cannabis Group Inc. Logo

Auxly Cannabis Group Inc.

CBWTF

(0.8)
Stock Price

0,02 USD

-19.67% ROA

-80.23% ROE

-1x PER

Market Cap.

46.645.146,49 USD

62.94% DER

0% Yield

-65.26% NPM

Auxly Cannabis Group Inc. Stock Analysis

Auxly Cannabis Group Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Auxly Cannabis Group Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.26x) suggests it's undervalued, making it an attractive opportunity for investors.

2 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

3 ROE

The stock's ROE indicates a negative return (-119.47%) on shareholders' equity, suggesting poor financial performance.

4 ROA

The stock's ROA (-38.66%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 DER

The company has a high debt to equity ratio (268%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Auxly Cannabis Group Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Auxly Cannabis Group Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Auxly Cannabis Group Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Auxly Cannabis Group Inc. Revenue
Year Revenue Growth
1997 1
1998 0 0%
1999 0 0%
2000 2.605.199 100%
2001 2.197.530 -18.55%
2002 1.609.109 -36.57%
2003 1.823.144 11.74%
2004 3.833.821 52.45%
2005 7.802.589 50.86%
2006 9.409.723 17.08%
2007 195.300 -4718.09%
2008 235.081 16.92%
2009 317.887 26.05%
2010 356.526 10.84%
2011 358.821 0.64%
2012 372.903 3.78%
2013 370.069 -0.77%
2014 275.050 -34.55%
2015 257.208 -6.94%
2016 231.233 -11.23%
2017 1.377.986 83.22%
2018 747.000 -84.47%
2019 8.352.000 91.06%
2020 50.796.000 83.56%
2021 83.829.000 39.41%
2022 94.472.000 11.27%
2023 112.844.000 16.28%
2023 101.078.000 -11.64%
2024 116.712.000 13.4%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Auxly Cannabis Group Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 8.448.712 100%
2018 0 0%
2019 0 0%
2020 524.000 100%
2021 298.000 -75.84%
2022 292.000 -2.05%
2023 0 0%
2023 497.000 100%
2024 92.000 -440.22%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Auxly Cannabis Group Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 267.348 100%
2009 216.187 -23.67%
2010 227.872 5.13%
2011 173.404 -31.41%
2012 165.276 -4.92%
2013 203.911 18.95%
2014 159.405 -27.92%
2015 141.672 -12.52%
2016 522.616 72.89%
2017 17.930.393 97.09%
2018 47.975.000 62.63%
2019 50.017.000 4.08%
2020 43.246.000 -15.66%
2021 36.125.000 -19.71%
2022 37.544.000 3.78%
2023 33.696.000 -11.42%
2023 31.833.000 -5.85%
2024 28.968.000 -9.89%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Auxly Cannabis Group Inc. EBITDA
Year EBITDA Growth
1997 -17.450
1998 -205.925 91.53%
1999 -268.162 23.21%
2000 2.234.222 112%
2001 1.850.753 -20.72%
2002 1.398.340 -32.35%
2003 1.283.709 -8.93%
2004 3.007.197 57.31%
2005 6.195.212 51.46%
2006 8.737.261 29.09%
2007 -14.891 58774.78%
2008 -32.266 53.85%
2009 108.700 129.68%
2010 119.654 9.15%
2011 115.472 -3.62%
2012 138.105 16.39%
2013 81.313 -69.84%
2014 46.443 -75.08%
2015 75.821 38.75%
2016 -440.519 117.21%
2017 -16.552.407 97.34%
2018 -44.870.000 63.11%
2019 -52.471.000 14.49%
2020 -44.646.000 -17.53%
2021 -27.735.000 -60.97%
2022 -25.217.000 -9.99%
2023 -19.872.000 -26.9%
2023 -30.946.000 35.78%
2024 -4.480.000 -590.76%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Auxly Cannabis Group Inc. Gross Profit
Year Gross Profit Growth
1997 1
1998 0 0%
1999 0 0%
2000 2.605.199 100%
2001 2.197.530 -18.55%
2002 1.609.109 -36.57%
2003 1.823.144 11.74%
2004 3.833.821 52.45%
2005 7.802.589 50.86%
2006 9.409.723 17.08%
2007 195.300 -4718.09%
2008 235.081 16.92%
2009 317.887 26.05%
2010 239.264 -32.86%
2011 235.832 -1.46%
2012 327.543 28%
2013 324.709 -0.87%
2014 229.690 -41.37%
2015 216.888 -5.9%
2016 193.433 -12.13%
2017 1.345.986 85.63%
2018 -188.000 815.95%
2019 -3.711.000 94.93%
2020 11.139.000 133.32%
2021 19.290.000 42.26%
2022 17.920.000 -7.65%
2023 18.352.000 2.35%
2023 -1.873.000 1079.82%
2024 24.180.000 107.75%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Auxly Cannabis Group Inc. Net Profit
Year Net Profit Growth
1997 -15.556
1998 -28.721 45.84%
1999 -629.726 95.44%
2000 -7.162.025 91.21%
2001 3.808.228 288.07%
2002 -6.987.899 154.5%
2003 -1.753.648 -298.48%
2004 -4.749.740 63.08%
2005 -6.089.559 22%
2006 9.111.185 166.84%
2007 -15.191 60077.52%
2008 -21.395 29%
2009 42.446 150.41%
2010 84.356 49.68%
2011 84.265 -0.11%
2012 105.216 19.91%
2013 62.298 -68.89%
2014 37.318 -66.94%
2015 32.547 -14.66%
2016 -229.577 114.18%
2017 -18.176.775 98.74%
2018 -66.988.000 72.87%
2019 -108.618.000 38.33%
2020 -87.431.000 -24.23%
2021 -45.910.000 -90.44%
2022 -130.293.000 64.76%
2023 130.484.000 199.85%
2023 -44.511.000 393.15%
2024 8.008.000 655.83%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Auxly Cannabis Group Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1997 0
1998 0 0%
1999 0 0%
2000 -2 100%
2001 1 300%
2002 -2 150%
2003 -1 0%
2004 -1 0%
2005 -1 100%
2006 1 200%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Auxly Cannabis Group Inc. Free Cashflow
Year Free Cashflow Growth
1997 -315.845
1998 34.314 1020.46%
1999 -1.007.535 103.41%
2000 -206.264 -388.47%
2001 -67.199 -206.95%
2002 183.442 136.63%
2003 225.381 18.61%
2004 93.990 -139.79%
2005 1.884.403 95.01%
2006 1.546.331 -21.86%
2007 -46.078 3455.9%
2008 23.682 294.57%
2009 69.436 65.89%
2010 90.265 23.08%
2011 94.563 4.55%
2012 76.368 -23.83%
2013 80.807 5.49%
2014 18.063 -347.36%
2015 32.599 44.59%
2016 -359.335 109.07%
2017 -23.181.333 98.45%
2018 -61.668.000 62.41%
2019 -116.921.000 47.26%
2020 -53.857.000 -117.1%
2021 -50.007.000 -7.7%
2022 -11.673.000 -328.4%
2023 6.610.000 276.6%
2023 2.527.000 -161.57%
2024 1.888.000 -33.85%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Auxly Cannabis Group Inc. Operating Cashflow
Year Operating Cashflow Growth
1997 -315.845
1998 34.314 1020.46%
1999 -1.007.535 103.41%
2000 -206.264 -388.47%
2001 -67.199 -206.95%
2002 183.442 136.63%
2003 225.381 18.61%
2004 93.990 -139.79%
2005 1.884.403 95.01%
2006 1.546.331 -21.86%
2007 -46.078 3455.9%
2008 23.682 294.57%
2009 70.453 66.39%
2010 90.265 21.95%
2011 94.563 4.55%
2012 76.368 -23.83%
2013 80.807 5.49%
2014 18.063 -347.36%
2015 32.599 44.59%
2016 -359.335 109.07%
2017 -11.406.994 96.85%
2018 -43.714.000 73.91%
2019 -79.119.000 44.75%
2020 -33.128.000 -138.83%
2021 -49.629.000 33.25%
2022 -2.481.000 -1900.36%
2023 8.214.000 130.2%
2023 2.541.000 -223.26%
2024 2.928.000 13.22%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Auxly Cannabis Group Inc. Capital Expenditure
Year Capital Expenditure Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 1.017 100%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 11.774.339 100%
2018 17.954.000 34.42%
2019 37.802.000 52.51%
2020 20.729.000 -82.36%
2021 378.000 -5383.86%
2022 9.192.000 95.89%
2023 1.604.000 -473.07%
2023 14.000 -11357.14%
2024 1.040.000 98.65%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Auxly Cannabis Group Inc. Equity
Year Equity Growth
1997 -312.715
1998 -291.435 -7.3%
1999 -1.942.888 85%
2000 -9.104.913 78.66%
2001 -5.296.685 -71.9%
2002 -12.284.584 56.88%
2003 -14.038.232 12.49%
2004 -18.737.972 25.08%
2005 -24.819.789 24.5%
2006 -15.578.155 -59.32%
2007 89.087 17586.45%
2008 118.268 24.67%
2009 203.582 41.91%
2010 291.252 30.1%
2011 376.185 22.58%
2012 481.401 21.86%
2013 543.699 11.46%
2014 581.017 6.42%
2015 694.677 16.36%
2016 383.987 -80.91%
2017 62.792.707 99.39%
2018 321.152.000 80.45%
2019 261.905.000 -22.62%
2020 191.529.000 -36.74%
2021 208.113.000 7.97%
2022 85.687.000 -142.88%
2023 51.047.000 -67.86%
2023 99.434.000 48.66%
2024 106.298.000 6.46%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Auxly Cannabis Group Inc. Assets
Year Assets Growth
1997 19.858.111
1998 25.741.997 22.86%
1999 46.690.509 44.87%
2000 42.410.491 -10.09%
2001 39.913.016 -6.26%
2002 35.068.198 -13.82%
2003 39.772.951 11.83%
2004 75.054.463 47.01%
2005 106.634.759 29.62%
2006 99.438.984 -7.24%
2007 120.324 -82542.68%
2008 158.204 23.94%
2009 272.343 41.91%
2010 380.167 28.36%
2011 456.230 16.67%
2012 547.849 16.72%
2013 604.146 9.32%
2014 612.051 1.29%
2015 721.734 15.2%
2016 416.945 -73.1%
2017 92.577.957 99.55%
2018 460.818.000 79.91%
2019 411.592.000 -11.96%
2020 378.963.000 -8.61%
2021 450.422.000 15.86%
2022 331.820.000 -35.74%
2023 261.904.000 -26.7%
2023 304.923.000 14.11%
2024 260.615.000 -17%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Auxly Cannabis Group Inc. Liabilities
Year Liabilities Growth
1997 20.170.826
1998 26.033.432 22.52%
1999 48.633.397 46.47%
2000 51.515.404 5.59%
2001 45.209.701 -13.95%
2002 47.352.782 4.53%
2003 53.811.183 12%
2004 93.792.435 42.63%
2005 131.454.548 28.65%
2006 115.017.139 -14.29%
2007 31.237 -368108.02%
2008 39.936 21.78%
2009 68.761 41.92%
2010 88.915 22.67%
2011 80.045 -11.08%
2012 66.448 -20.46%
2013 60.447 -9.93%
2014 31.034 -94.78%
2015 27.057 -14.7%
2016 32.958 17.9%
2017 29.785.250 99.89%
2018 139.666.000 78.67%
2019 149.687.000 6.69%
2020 187.434.000 20.14%
2021 242.309.000 22.65%
2022 246.133.000 1.55%
2023 210.857.000 -16.73%
2023 205.489.000 -2.61%
2024 154.317.000 -33.16%

Auxly Cannabis Group Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.09
Net Income per Share
-0.04
Price to Earning Ratio
-1x
Price To Sales Ratio
0.43x
POCF Ratio
4.11
PFCF Ratio
5.12
Price to Book Ratio
0.43
EV to Sales
1.01
EV Over EBITDA
-6.46
EV to Operating CashFlow
10.04
EV to FreeCashFlow
12.2
Earnings Yield
-1
FreeCashFlow Yield
0.2
Market Cap
0,05 Bil.
Enterprise Value
0,11 Bil.
Graham Number
0.26
Graham NetNet
-0.09

Income Statement Metrics

Net Income per Share
-0.04
Income Quality
-0.24
ROE
-0.5
Return On Assets
-0.28
Return On Capital Employed
-0.06
Net Income per EBT
1.21
EBT Per Ebit
5.91
Ebit per Revenue
-0.09
Effective Tax Rate
-0.21

Margins

Sales, General, & Administrative to Revenue
0.29
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.03
Gross Profit Margin
0.24
Operating Profit Margin
-0.09
Pretax Profit Margin
-0.54
Net Profit Margin
-0.65

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.01
Free CashFlow per Share
0.01
Capex to Operating CashFlow
0.18
Capex to Revenue
0.02
Capex to Depreciation
0.18
Return on Invested Capital
-0.26
Return on Tangible Assets
-0.2
Days Sales Outstanding
65.44
Days Payables Outstanding
165.59
Days of Inventory on Hand
129.15
Receivables Turnover
5.58
Payables Turnover
2.2
Inventory Turnover
2.83
Capex per Share
0

Balance Sheet

Cash per Share
0,01
Book Value per Share
0,09
Tangible Book Value per Share
0.06
Shareholders Equity per Share
0.09
Interest Debt per Share
0.07
Debt to Equity
0.63
Debt to Assets
0.26
Net Debt to EBITDA
-3.75
Current Ratio
0.8
Tangible Asset Value
0,08 Bil.
Net Current Asset Value
-0,08 Bil.
Invested Capital
167461000
Working Capital
-0,02 Bil.
Intangibles to Total Assets
0.11
Average Receivables
0,02 Bil.
Average Payables
0,04 Bil.
Average Inventory
31973500
Debt to Market Cap
1.43

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Auxly Cannabis Group Inc. Dividends
Year Dividends Growth

Auxly Cannabis Group Inc. Profile

About Auxly Cannabis Group Inc.

Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. The company focuses on developing, manufacturing, and distributing cannabis products for wellness and recreational consumers. It offers cannabis products under various forms, including vape catridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy under the brands KOLAB PROJECT, Dosecann, BACK FORTY, and Foray. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Toronto, Canada.

CEO
Mr. Hugo M. Alves
Employee
369
Address
777 Richmond Street West
Toronto, M6J 0C2

Auxly Cannabis Group Inc. Executives & BODs

Auxly Cannabis Group Inc. Executives & BODs
# Name Age
1 Mr. Vladimir Klacar
Senior Vice President of Regulatory Affairs & Planning
70
2 Mr. Kevin Furet
Chief Cultivation & Genetics Officer
70
3 Mr. Michael David Lickver
President
70
4 Mr. Travis Wong
Chief Financial Officer
70
5 Mr. Ron Fichter
General Counsel & Corporate Secretary
70
6 Mr. Andrew MacMillan
Senior Vice President of Commercial
70
7 Mr. Hugo M. Alves
Chief Executive Officer & Director
70

Auxly Cannabis Group Inc. Competitors